The funding will support a project to develop diagnostic platforms that can detect drug-resistant infections and identify the right antibiotic in real time.
Lumos Diagnostics receives FDA clearance for a test that helps to determine when antibiotics are needed for respiratory infections.
A randomized controlled trial in Vietnam finds that the use of point-of-care C-reactive protein testing reduced antibiotic prescribing.
The recipients are Vedanta Biosciences, whose lead candidate is a microbiome-directed C difficile therapy, and diagnostics company Pattern Bioscience for rapid bacterial susceptibility tests.
For bacterial infections, the test had a sensitivity of 93% and a specificity of 88%, while viral sensitivity was 70%.
Diagnostics company Avails Medical announced today that it has received an additional $1.7 million in funding from CARB-X (the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) to continue developing a rapid electronic antibiotic susceptibility test (AST).
Becton, Dickinson and Company (BD) and Accelerate Diagnostics yesterday announced a commercial collaboration agreement to bring rapid identification and antibiotic susceptibility tests to more clinicians and patients worldwide.
A coalition of public interest, animal welfare, and environmental groups is criticizing McDonald's for backing away from a commitment to reduce the use of medically important antibiotics in its beef supply chain.
Researchers in Austria are reporting the identification of a second strain of extensively drug-resistant (XDR) gonorrhea.
Blood culture rate fell 33%, and broad-spectrum antibiotic use dropped 13% in PICUs.
